Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma.

Puglisi R, Bellenghi M, Pontecorvi G, Gulino A, Petrini M, Felicetti F, Bottero L, Mattia G, Carè A.

Oncotarget. 2018 Jan 9;9(7):7567-7581. doi: 10.18632/oncotarget.24085. eCollection 2018 Jan 26.

2.

Aberrant HRAS transcript processing underlies a distinctive phenotype within the RASopathy clinical spectrum.

Pantaleoni F, Lev D, Cirstea IC, Motta M, Lepri FR, Bottero L, Cecchetti S, Linger I, Paolacci S, Flex E, Novelli A, Carè A, Ahmadian MR, Stellacci E, Tartaglia M.

Hum Mutat. 2017 Jul;38(7):798-804. doi: 10.1002/humu.23224. Epub 2017 May 3.

PMID:
28390077
3.

AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.

Felli N, Errico MC, Pedini F, Petrini M, Puglisi R, Bellenghi M, Boe A, Felicetti F, Mattia G, De Feo A, Bottero L, Tripodo C, Carè A.

Oncogene. 2016 Jun 9;35(23):3016-26. doi: 10.1038/onc.2015.357. Epub 2015 Oct 5.

4.

SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B.

Bellenghi M, Puglisi R, Pedini F, De Feo A, Felicetti F, Bottero L, Sangaletti S, Errico MC, Petrini M, Gesumundo C, Denaro M, Felli N, Pasquini L, Tripodo C, Colombo MP, Carè A, Mattia G.

J Pathol. 2015 Jul;236(3):315-25. doi: 10.1002/path.4535. Epub 2015 Apr 20.

PMID:
25802234
5.

Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis.

Flex E, Jaiswal M, Pantaleoni F, Martinelli S, Strullu M, Fansa EK, Caye A, De Luca A, Lepri F, Dvorsky R, Pannone L, Paolacci S, Zhang SC, Fodale V, Bocchinfuso G, Rossi C, Burkitt-Wright EM, Farrotti A, Stellacci E, Cecchetti S, Ferese R, Bottero L, Castro S, Fenneteau O, Brethon B, Sanchez M, Roberts AE, Yntema HG, Van Der Burgt I, Cianci P, Bondeson ML, Cristina Digilio M, Zampino G, Kerr B, Aoki Y, Loh ML, Palleschi A, Di Schiavi E, Carè A, Selicorni A, Dallapiccola B, Cirstea IC, Stella L, Zenker M, Gelb BD, Cavé H, Ahmadian MR, Tartaglia M.

Hum Mol Genet. 2014 Aug 15;23(16):4315-27. doi: 10.1093/hmg/ddu148. Epub 2014 Apr 4.

6.

HOXB1 restored expression promotes apoptosis and differentiation in the HL60 leukemic cell line.

Petrini M, Felicetti F, Bottero L, Errico MC, Morsilli O, Boe A, De Feo A, Carè A.

Cancer Cell Int. 2013 Oct 22;13(1):101. doi: 10.1186/1475-2867-13-101.

7.

miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.

Felli N, Felicetti F, Lustri AM, Errico MC, Bottero L, Cannistraci A, De Feo A, Petrini M, Pedini F, Biffoni M, Alvino E, Negrini M, Ferracin M, Mattia G, Carè A.

PLoS One. 2013;8(2):e56824. doi: 10.1371/journal.pone.0056824. Epub 2013 Feb 21.

8.

The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.

Errico MC, Felicetti F, Bottero L, Mattia G, Boe A, Felli N, Petrini M, Bellenghi M, Pandha HS, Calvaruso M, Tripodo C, Colombo MP, Morgan R, Carè A.

Int J Cancer. 2013 Aug 15;133(4):879-92. doi: 10.1002/ijc.28097. Epub 2013 Mar 13.

9.

Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma.

Mattia G, Errico MC, Felicetti F, Petrini M, Bottero L, Tomasello L, Romania P, Boe A, Segnalini P, Di Virgilio A, Colombo MP, Carè A.

Pigment Cell Melanoma Res. 2011 Oct;24(5):953-65. doi: 10.1111/j.1755-148X.2011.00881.x.

10.

Caveolin-1 tumor-promoting role in human melanoma.

Felicetti F, Parolini I, Bottero L, Fecchi K, Errico MC, Raggi C, Biffoni M, Spadaro F, Lisanti MP, Sargiacomo M, Carè A.

Int J Cancer. 2009 Oct 1;125(7):1514-22. doi: 10.1002/ijc.24451.

11.

Laparoscopic appendectomies: experience of a surgical unit.

Gurrado A, Faillace G, Bottero L, Frola C, Stefanini P, Piccinni G, Longoni M.

Minim Invasive Ther Allied Technol. 2009;18(4):242-7. doi: 10.1080/13645700903053840.

PMID:
20334502
12.

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Carè A.

Cancer Res. 2008 Apr 15;68(8):2745-54. doi: 10.1158/0008-5472.CAN-07-2538.

13.

Oncogenic HoxB7 requires TALE cofactors and is inactivated by a dominant-negative Pbx1 mutant in a cell-specific manner.

Fernandez LC, Errico MC, Bottero L, Penkov D, Resnati M, Blasi F, Caré A.

Cancer Lett. 2008 Aug 8;266(2):144-55. doi: 10.1016/j.canlet.2008.02.042. Epub 2008 Apr 2.

PMID:
18378073
14.

Use of human fibrin glue (Tissucol) versus staples for mesh fixation in laparoscopic transabdominal preperitoneal hernioplasty: a prospective, randomized study.

Lovisetto F, Zonta S, Rota E, Mazzilli M, Bardone M, Bottero L, Faillace G, Longoni M.

Ann Surg. 2007 Feb;245(2):222-31.

15.

Laparoscopic transabdominal preperitoneal (TAPP) hernia repair: surgical phases and complications.

Lovisetto F, Zonta S, Rota E, Bottero L, Faillace G, Turra G, Fantini A, Longoni M.

Surg Endosc. 2007 Apr;21(4):646-52. Epub 2006 Nov 14.

PMID:
17103276
16.

Role of PLZF in melanoma progression.

Felicetti F, Bottero L, Felli N, Mattia G, Labbaye C, Alvino E, Peschle C, Colombo MP, Carè A.

Oncogene. 2004 Jun 3;23(26):4567-76.

PMID:
15077196
17.

Laparoscopic appendectomy in Italy: an appraisal of 26,863 cases.

Agresta F, De Simone P, Leone L, Arezzo A, Biondi A, Bottero L, Catena F, Conzo G, Del Genio G, Fersini A, Guerrieri M, Illomei G, Tonelli P, Vitellaro M, Docimo G, Crucitti A; Italian Society Of Young Surgeons (SPIGC).

J Laparoendosc Adv Surg Tech A. 2004 Feb;14(1):1-8.

PMID:
15035836
18.

Electromyographic assessment of rectus abdominis muscle function after deep inferior epigastric perforator flap surgery.

Bottero L, Lefaucheur JP, Fadhul S, Raulo Y, Collins ED, Lantieri L.

Plast Reconstr Surg. 2004 Jan;113(1):156-61.

PMID:
14707633
19.

HOXB7 expression is regulated by the transcription factors NF-Y, YY1, Sp1 and USF-1.

Meccia E, Bottero L, Felicetti F, Peschle C, Colombo MP, Carè A.

Biochim Biophys Acta. 2003 Apr 15;1626(1-3):1-9.

PMID:
12697323
20.

HOXB7: a key factor for tumor-associated angiogenic switch.

Carè A, Felicetti F, Meccia E, Bottero L, Parenza M, Stoppacciaro A, Peschle C, Colombo MP.

Cancer Res. 2001 Sep 1;61(17):6532-9.

21.
22.

[Isokinetic dynamometric evaluation of rehabilitation results of elbow extension in tetraplegic patients].

Bottero L, Houssin B, Cormerais A, Revol M, Servant JM.

Ann Chir Plast Esthet. 2000 Aug;45(4):419-24. French.

PMID:
10989518
23.

[Anatomical study of the distal tendon of the brachial biceps muscle. Application to biceps-triceps transfer in tetraplegic patients].

Bottero L, Revol M, Servant JM.

Ann Chir Plast Esthet. 1999 Oct;44(5):541-4. French.

PMID:
10609377
24.

Functional outcome after surgery for trigonocephaly.

Bottero L, Lajeunie E, Arnaud E, Marchac D, Renier D.

Plast Reconstr Surg. 1998 Sep;102(4):952-8; discussion 959-60.

PMID:
9734408
25.

Organ culture in 3-dimensional matrix: in vitro model for evaluating biological compliance of synthetic meshes for abdominal wall repair.

Dasdia T, Bazzaco S, Bottero L, Buffa R, Ferrero S, Campanelli G, Dolfini E.

J Biomed Mater Res. 1998 Summer;43(2):204-9.

PMID:
9619439
26.

[Mental prognosis of trigonocephaly and therapeutic implications].

Bottero L, Lajeunie E, Arnaud E, Marchac D, Renier D.

Ann Chir Plast Esthet. 1997 Aug;42(4):296-304. French.

PMID:
9768122
27.

Antley-Bixler syndrome. Description of two new cases and a review of the literature.

Bottero L, Cinalli G, Labrune P, Lajeunie E, Renier D.

Childs Nerv Syst. 1997 May;13(5):275-80; discussion 281. Review.

PMID:
9224917
28.

[Antley-Bixler syndrome. Description of two new cases and review of the literature. Prognostic and therapeutic aspects].

Bottero L, Cinalli G, Labrune P, Lajeunie E, Marchac D, Renier D.

Ann Chir Plast Esthet. 1997 Feb;42(1):48-55. Review. French.

PMID:
9768136
29.

HOXB cluster genes in activated natural killer lymphocytes: expression from 3'-->5' cluster side and proliferative function.

Quaranta MT, Petrini M, Tritarelli E, Samoggia P, Carè A, Bottero L, Testa U, Peschle C.

J Immunol. 1996 Sep 15;157(6):2462-9.

PMID:
8805646
30.

[Recurrent inguinal hernia. Propositions of classification and surgical strategy].

Campanelli G, Cavagnoli R, Bottero L, De Simone M, Pietri P.

J Chir (Paris). 1996 Sep;133(6):270-3. French.

PMID:
8949270
31.

[Use of polypropylene (Marlex) prosthesis in the surgical treatment of inguinal and crural hernia].

Campanelli GP, Cavagnoli R, Buonocore G, Gabrielli F, Bottero L, De Simone M, Pietri P.

Minerva Chir. 1995 Jun;50(6):563-8. Italian.

PMID:
7501213
32.

Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors.

Sposi NM, Zon LI, Carè A, Valtieri M, Testa U, Gabbianelli M, Mariani G, Bottero L, Mather C, Orkin SH, et al.

Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6353-7.

33.

Differential activation of homeobox genes by retinoic acid in human embryonal carcinoma cells.

Bottero L, Simeone A, Arcioni L, Acampora D, Andrews PW, Boncinelli E, Mavilio F.

Recent Results Cancer Res. 1991;123:133-43. No abstract available.

PMID:
1684061
34.

Molecular mechanisms underlying the expression of the human HOX-5.1 gene.

Cianetti L, Di Cristofaro A, Zappavigna V, Bottero L, Boccoli G, Testa U, Russo G, Boncinelli E, Peschle C.

Nucleic Acids Res. 1990 Aug 11;18(15):4361-8.

35.

Constitutive expression and abnormal glycosylation of transferrin receptor in acute T-cell leukemia.

Petrini M, Pelosi-Testa E, Sposi NM, Mastroberardino G, Camagna A, Bottero L, Mavilio F, Testa U, Peschle C.

Cancer Res. 1989 Dec 15;49(24 Pt 1):6989-96.

36.

Expression of protein kinase C genes during ontogenic development of the central nervous system.

Sposi NM, Bottero L, Cossu G, Russo G, Testa U, Peschle C.

Mol Cell Biol. 1989 May;9(5):2284-8.

37.

Human acute myelogenous and lymphoid leukemias: pattern of expression of cellular oncogenes.

Sposi NM, Mavilio F, Petrini M, Bottero L, Zappavigna V, Mastroberardino G, De Rossi G, Amadori S, Mandelli F, Peschle C.

Haematologica. 1987 Nov-Dec;72(6 Suppl):23-6. No abstract available.

PMID:
3127292
38.

Expression of transferrin receptors: differential regulatory mechanisms in monocytes-macrophages versus other hemopoietic cells.

Testa U, Camagna A, Giannella G, Pelosi-Testa E, Petrini M, Samoggia P, Montesoro E, Bottero L, Sposi NM, Salvo G, et al.

Ann N Y Acad Sci. 1987;511:131-7. No abstract available.

PMID:
3481524
39.

Expression of c-fos in human normal and neoplastic monocyte-macrophage differentiation.

Sposi NM, Petrini M, Mavilio F, Testa U, Bottero L, Pelosi E, Mastroberardino G, Amadori S, Mandelli F, Peschle C.

Ann N Y Acad Sci. 1987;511:277-83. No abstract available.

PMID:
3125780
40.

Differential regulation of transferrin receptor gene expression in human hemopoietic cells: molecular and cellular aspects.

Testa U, Testa EP, Mavilio F, Petrini M, Sposi NM, Petti S, Samoggia P, Montesoro E, Giannella G, Bottero L, et al.

J Recept Res. 1987;7(1-4):355-75. No abstract available.

PMID:
3114478
41.

Expression of cellular oncogenes in primary cells from human acute leukemias.

Mavilio F, Sposi NM, Petrini M, Bottero L, Marinucci M, De Rossi G, Amadori S, Mandelli F, Peschle C.

Proc Natl Acad Sci U S A. 1986 Jun;83(12):4394-8.

42.

A human homoeo box gene specifically expressed in spinal cord during embryonic development.

Simeone A, Mavilio F, Bottero L, Giampaolo A, Russo G, Faiella A, Boncinelli E, Peschle C.

Nature. 1986 Apr 24-30;320(6064):763-5.

PMID:
3453105
43.

Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia.

Peschle C, Mavilio F, Sposi NM, Giampaolo A, Caré A, Bottero L, Bruno M, Mastroberardino G, Gastaldi R, Testa MG, et al.

Proc Natl Acad Sci U S A. 1984 Sep;81(17):5514-8.

44.

Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies.

Pessano S, Palumbo A, Ferrero D, Pagliardi GL, Bottero L, Lai SK, Meo P, Carter C, Hubbell H, Lange B, et al.

Blood. 1984 Jul;64(1):275-81.

45.

Human granulocyte surface molecules identified by murine monoclonal antibodies.

Skubitz KM, Pessano S, Bottero L, Ferrero D, Rovera G, August JT.

J Immunol. 1983 Oct;131(4):1882-8.

PMID:
6619543
46.

Differentiation antigens of human hemopoietic cells: patterns of reactivity of two monoclonal antibodies.

Pessano S, Bottero L, Faust J, Trucco M, Palumbo A, Pegoraro L, Lange B, Brezin C, Borst J, Terhorst C, Rovera G.

Cancer Res. 1983 Oct;43(10):4812-5.

47.

Dedifferentiation, maldifferentiation or arrested differentiation in human acute myelogenous leukemias.

Pagliardi GL, Pessano S, Palumbo A, Levis A, Bottero L, Ferrero D, Lange B, Rovera G.

Prog Clin Biol Res. 1983;132C:65-73. No abstract available.

PMID:
6579566
48.

Induction of differentiation of human myeloid leukemias by phorbol diesters: phenotypic changes and mode of action.

Rovera G, Ferrero D, Pagliardi GL, Vartikar J, Pessano S, Bottero L, Abraham S, Lebman D.

Ann N Y Acad Sci. 1982 Dec 10;397:211-20.

PMID:
6961843
49.

A monoclonal antibody that detects expression of transferrin receptor in human erythroid precursor cells.

Lebman D, Trucco M, Bottero L, Lange B, Pessano S, Rovera G.

Blood. 1982 Mar;59(3):671-8.

50.

A monoclonal antibody with specificity for leukemic cells transformed by defective avian leukemia viruses.

Jurdic P, Moscovici C, Pessano S, Bottero L, Rovera G.

J Cell Physiol Suppl. 1982;2:85-95.

PMID:
6302112

Supplemental Content

Loading ...
Support Center